Avanos Medical Inc (NYSE: AVNS) is -28.58% lower on its value in year-to-date trading and has touched a low of $15.89 and a high of $25.36 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AVNS stock was last observed hovering at around $16.03 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $16.02, the stock is -11.12% and -17.86% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.13 million and changing -0.06% at the moment leaves the stock -22.72% off its SMA200. AVNS registered -29.74% loss for a year compared to 6-month loss of -16.48%. The firm has a 50-day simple moving average (SMA 50) of $19.6354 and a 200-day simple moving average (SMA200) of $20.74885.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -13.87% gain in the last 1 month and extending the period to 3 months gives it a -31.54%, and is -5.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.59% over the week and 3.13% over the month.
Avanos Medical Inc (AVNS) has around 3771 employees, a market worth around $735.77M and $681.50M in sales. Current P/E ratio is 47.49 and Fwd P/E is 9.42. Profit margin for the company is 2.30%. Distance from 52-week low is 0.82% and -36.83% from its 52-week high. The company has generated returns on investments over the last 12 months (1.11%).
The EPS is expected to grow by 28.64% this year.
Avanos Medical Inc (AVNS) Top Institutional Holders
363.0 institutions hold shares in Avanos Medical Inc (AVNS), with institutional investors hold 99.03% of the company’s shares. The shares outstanding are 45.95M, and float is at 44.88M with Short Float at 1.62%. Institutions hold 96.09% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.01 million shares valued at $139.66 million. The investor’s holdings represent 15.1758% of the AVNS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.27 million shares valued at $104.98 million to account for 11.4072 of the shares outstanding. The other top investors are RGM CAPITAL, LLC which holds 3.17 million shares representing 6.8646% and valued at over $63.18 million, while DIMENSIONAL FUND ADVISORS LP holds 5.5793 of the shares totaling 2.58 million with a market value of $51.35 million.
Avanos Medical Inc (AVNS) Insider Activity
The most recent transaction is an insider sale by Greiner Michael, the company’s SVP – Chief Financial Officer. SEC filings show that Greiner Michael sold 8,000 shares of the company’s common stock on Mar 14 ’24 at a price of $19.12 per share for a total of $0.15 million. Following the sale, the insider now owns 0.15 million shares.
Avanos Medical Inc disclosed in a document filed with the SEC on Mar 11 ’24 that Shimer Julie Ann (Director) bought a total of 500 shares of the company’s common stock. The trade occurred on Mar 11 ’24 and was made at $19.85 per share for $9925.0. Following the transaction, the insider now directly holds 50090.0 shares of the AVNS stock.
